Medicine
Lithium carbonate 300 mg capsule
Lithium carbonate 300 mg capsule is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Lithium carbonate
- Brand
- Sold under the generic name
- Strength
- 300 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 30 capsules, 100 capsules, 500 capsules and 39 more
- Manufacturers
- Alembic PharmaceuticalsIndiaCamber PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaBryant Ranch PrepackHikma PharmaceuticalsProficient RxAmerican Health PackagingAphena Pharma Solutions - TennesseeCardinal HealthPD-Rx Pharmaceuticals12 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). PROTECT FROM MOISTURE.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 November 1980
- Identifiers
- RxCUI 197889, 197893, 311355 +2DailyMed set ID 2b81eabc-5c5a-4b63-88d4-3f13b45a683e, 0e6b0a2d-b79c-44d8-b785-5267df9e8f72, d1800f34-3d67-4b2f-874e-8639b125d853 +12NDC 71610-557, 55154-4920, 46708-304 +13Application ANDA090702, NDA017812, ANDA079159 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 12 labelers. The register lists 42 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 capsule in 1 bottle | 46708-304-30 | Alembic PharmaceuticalsIndia | 27 December 2016 |
| 100 capsule in 1 bottle | 46708-304-31 | Alembic PharmaceuticalsIndia | 27 December 2016 |
| 500 capsule in 1 bottle | 46708-304-71 | Alembic PharmaceuticalsIndia | 27 December 2016 |
| 1000 capsule in 1 bottle | 46708-304-91 | Alembic PharmaceuticalsIndia | 27 December 2016 |
| 30 capsule in 1 bottle | 62332-014-30 | Alembic PharmaceuticalsIndia | 27 December 2016 |
| 100 capsule in 1 bottle | 62332-014-31 | Alembic PharmaceuticalsIndia | 27 December 2016 |
| 500 capsule in 1 bottle | 62332-014-71 | Alembic PharmaceuticalsIndia | 27 December 2016 |
| 1000 capsule in 1 bottle | 62332-014-91 | Alembic PharmaceuticalsIndia | 27 December 2016 |
| 100 capsule in 1 bottle | 31722-545-01 | Camber PharmaceuticalsIndia | 15 December 2009 |
| 30 capsule in 1 blister pack | 31722-545-03 | Camber PharmaceuticalsIndia | 15 December 2009 |
| 500 capsule in 1 bottle | 31722-545-05 | Camber PharmaceuticalsIndia | 15 December 2009 |
| 1000 capsule in 1 bottle | 31722-545-10 | Camber PharmaceuticalsIndia | 15 December 2009 |
| 30 capsule in 1 bottle | 31722-545-30 | Camber PharmaceuticalsIndia | 15 December 2009 |
| 5000 capsule in 1 bottle | 31722-545-50 | Camber PharmaceuticalsIndia | 15 December 2009 |
| 100 capsule in 1 bottle | 68462-221-01 | Glenmark PharmaceuticalsIndia | 3 February 2009 |
| 1000 capsule in 1 bottle | 68462-221-10 | Glenmark PharmaceuticalsIndia | 3 February 2009 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 68462-221-11 | Glenmark PharmaceuticalsIndia | 3 February 2009 |
| 100 capsule, gelatin coated in 1 bottle | 0054-0890-25 | Hikma Pharmaceuticals | 16 August 2026 |
| 1000 capsule, gelatin coated in 1 bottle | 0054-0890-31 | Hikma Pharmaceuticals | 16 August 2026 |
| 100 capsule, gelatin coated in 1 bottle | 0054-2527-25 | Hikma Pharmaceuticals | 26 November 1980 |
| 1000 capsule, gelatin coated in 1 bottle | 0054-2527-31 | Hikma Pharmaceuticals | 26 November 1980 |
| 10 capsule, gelatin coated in 1 blister pack | 0054-8527-25 | Hikma Pharmaceuticals | 26 November 1980 |
| 60 capsule in 1 bottle | 71335-0120-1 | Bryant Ranch Prepack | 16 December 2021 |
| 100 capsule in 1 bottle | 71335-0120-2 | Bryant Ranch Prepack | 16 December 2021 |
| 30 capsule in 1 bottle | 71335-0120-3 | Bryant Ranch Prepack | 16 December 2021 |
| 90 capsule in 1 bottle | 71335-0120-4 | Bryant Ranch Prepack | 16 December 2021 |
| 120 capsule in 1 bottle | 71335-0120-5 | Bryant Ranch Prepack | 16 December 2021 |
| 60 capsule in 1 bottle | 71335-1006-1 | Bryant Ranch Prepack | 17 May 2019 |
| 100 capsule in 1 bottle | 71335-1006-2 | Bryant Ranch Prepack | 17 May 2019 |
| 30 capsule in 1 bottle | 71335-1006-3 | Bryant Ranch Prepack | 18 October 2019 |
| 90 capsule in 1 bottle | 71335-1006-4 | Bryant Ranch Prepack | 4 October 2019 |
| 120 capsule in 1 bottle | 71335-1006-5 | Bryant Ranch Prepack | 17 May 2019 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 60687-806-01 | American Health Packaging | 16 June 2024 |
| 120 capsule in 1 bottle | 71610-557-70 | Aphena Pharma Solutions - Tennessee | 20 May 2021 |
| 10 blister pack in 1 bag / 1 capsule, gelatin coated in 1 blister pack | 55154-4920-0 | Cardinal Health | 28 July 1987 |
| 100 capsule, gelatin coated in 1 bottle, plastic | 72789-173-01 | PD-Rx Pharmaceuticals | 9 March 2021 |
| 30 capsule in 1 bottle | 63187-304-30 | Proficient Rx | 2 May 2016 |
| 60 capsule in 1 bottle | 63187-304-60 | Proficient Rx | 2 May 2016 |
| 90 capsule in 1 bottle | 63187-304-90 | Proficient Rx | 2 May 2016 |
| 30 capsule in 1 blister pack | 70518-0668-0 | Remedyrepack | 10 August 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 April 1970 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Lithium carbonate
Clinical summary
Lithium carbonate is a mood stabilizer indicated as monotherapy for the treatment of bipolar I disorder, among other approved uses. It is available as capsules, extended-release tablets and tablets for oral use. MedsAcross supplies Lithium carbonate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Lithium carbonateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lithium Carbonate prescribing information (Hikma Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Lithium carbonate 300 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.